Sitemap
December 10, 2011 Articles
Filter by Available Specialty
- 12-week warfarin assessment noninferior to 4-week assessment
- 12-year-old girl presents with worsening vision
- Addition of radiation to ADT improved OS in locally advanced prostate cancer
- Adoption of refractive cataract surgery essential for anterior segment surgeons
- Are we measuring practice success correctly?
- Biomarkers identified to predict benefit from maintenance erlotinib
- CC genotype associated with sustained virologic response to HCV
- Coffee consumption linked to lower risk for basal cell carcinoma
- Computer program improved communication between oncologists, patients
- Dietary patterns associated with increased C-peptide, colorectal cancer risk in women
- EGFR expression identified greatest cetuximab benefit in patients with NSCLC
- Epigenetic therapy improved PFS, OS in NSCLC
- FDA approves cetuximab for metastatic head and neck cancer
- FDA approves first cord blood treatment
- FDA approves orphan drug status for ruxolitinib
- FDA revokes indication for bevacizumab in metastatic breast cancer
- Fecal immunochemical test good alternative when colonoscopy capacity limited
- Fewer nitrates in hot dogs possibly linked to reduced colon cancer deaths
- Glaucoma treatment efforts may benefit from emphasis on disease modification
- Guidelines can help identify unmet palliative care needs
- Increased dietary fiber, whole grain intake reduced colorectal cancer risk
- Inflammation common after pterygium surgery with amniotic membrane transplantation
- Intracorneal ring segment, phakic IOL implantation enable keratoconus management without keratoplasty
- Metastatic breast carcinoma with mixed response to therapy
- Minor complications can occur with collagen cross-linking
- MITF may be an oncogene for familial, sporadic melanoma
- Modified capsule expander may help in cases of subluxation and phacodonesis
- Multidisciplinary program bested traditional method in HCV treatment
- Novel steroidal compound has clinical activity in advanced breast cancer
- Ocriplasmin shows promise for assortment of retinal diseases
- Often unrecognized, depression can be a debilitating side effect of cancer
- Older, sicker patients less likely to get recommended therapies
- Pharmacogenomic testing consent failed to yield selection bias
- Premium IOLs a challenge to adopt into cataract practice
- Progression of prostate cancer in an 80-year-old male
- Prostatectomy outcomes better at academic institutions
- R1507 provided no advantage over erlotinib for advanced NSCLC
- Reduced alcohol consumption during adolescence may decrease breast cancer risk
- Reduced-intensity heparin may decrease VTE recurrence
- Rituximab plus chemotherapy improved survival in mantle cell lymphoma
- Skin cancer risk increased along with tanning bed use
- Surgeon explains transition from peristaltic to venturi phaco
- Up-and-coming glaucoma therapeutics and devices showcased
- Vaccine may be active in breast, ovarian cancers
- VEGF-inhibitor axitinib valid second-line treatment for RCC